Publications by authors named "Orhan Yılmaz"

Article Synopsis
  • - The study reviewed the effectiveness of topical medications for diabetic neuropathic pain (DNP) and compared them with oral pain relief options.
  • - The most promising topical treatments identified were 8% Capsaicin patches and 5% Lidocaine patches, along with evidence supporting topical clonidine, gabapentin, and amitriptyline.
  • - Topical medications could be viable alternatives to oral medications for DNP, and further research is needed on combining different topical treatments for better effectiveness.
View Article and Find Full Text PDF
Article Synopsis
  • * The IL-17 pathway has been identified as a key player in HS inflammation, leading to the development of IL-17 inhibitors like secukinumab and bimekizumab, both of which have gained regulatory approvals for treating moderate-to-severe HS.
  • * Ongoing clinical trials are exploring newer drugs like sonelokimab and izokibep, which show promise in treating HS, while this review summarizes the latest findings and advancements in understanding
View Article and Find Full Text PDF

Atopic dermatitis (AD) is a common chronic inflammatory skin disease involving complex immune dysregulation, including the OX40-OX40L pathway. Rocatinlimab and amlitelimab, monoclonal antibodies targeting OX40 and OX40L, respectively, have shown promise in treating moderate-to-severe AD. Both therapies have demonstrated significant efficacy in reducing disease severity, with favorable safety profiles and no serious treatment-related adverse events.

View Article and Find Full Text PDF
Article Synopsis
  • - Atopic dermatitis (AD) is a widespread chronic skin condition, mainly affecting kids, caused by a mix of genetic and environmental factors that disrupt skin barriers and immune function, particularly through the action of cytokines like IL-13.
  • - New treatments are urgently needed for moderate-to-severe AD, and recent phase III trials show that IL-13 inhibitors like tralokinumab and lebrikizumab are safe and effective, with tralokinumab now available in both Europe and the USA.
  • - Other IL-13 targeted therapies, like cendakimab (which is promising from phase II trials) and eblasakimab (currently in phase II after successful phase I results), are under investigation and may
View Article and Find Full Text PDF
Article Synopsis
  • - Spontaneous regression (SR) refers to the unexpected reduction or disappearance of a tumor without treatment, but it is rare in both breast cancer and other cancer types.
  • - The study included two cases of SR but lacked sufficient evidence to clarify the underlying mechanisms, and neither patient showed PD-L1, contradicting its proposed antitumoral role.
  • - One patient was the first documented case with Cerb B2 positivity and an early SR period, suggesting that thorough examinations before surgery could increase SR occurrences in breast cancer and aid in understanding the underlying mechanisms.
View Article and Find Full Text PDF
Article Synopsis
  • Atopic dermatitis is a common, chronic skin condition that causes itchy, red, and scaly patches, affecting around 20% of children and 7-14% of adults, depending on the country.
  • The condition arises from a combination of genetic, immune, and environmental factors, leading researchers to discover new treatment options targeting inflammation to alleviate symptoms.
  • Current treatments range from standard options like emollients and corticosteroids to newer therapies such as biologics (e.g., dupilumab) and small molecule inhibitors, each with specific mechanisms and varying effectiveness and safety profiles.
View Article and Find Full Text PDF
Article Synopsis
  • - Atopic dermatitis (AD) is a chronic skin condition causing severe itching and eczema, which impacts patients' health and quality of life due to its complex causes like genetics, immune issues, and environmental factors.
  • - Current treatments for AD range from topical creams to advanced options like Janus kinase inhibitors and biologics; however, newer extended half-life antibodies are being developed to reduce dosing frequency while still being effective.
  • - Two promising antibodies, APG777 and IMG-007, are currently in phase 2 trials and aim to improve AD symptom management with fewer injections, potentially enhancing patient compliance and reducing healthcare needs.
View Article and Find Full Text PDF
Article Synopsis
  • - Psoriasis is a chronic skin disease affecting 2-3% of people globally, with traditional treatments like methotrexate having limited effectiveness and potential side effects requiring ongoing monitoring.
  • - New biologic drugs provide better safety and efficacy but are costly and require injections, leading to increased interest in developing targeted oral therapies.
  • - Promising small molecules, such as phosphodiesterase 4 and TYK2 inhibitors, along with other oral agents targeting specific pathways, are being researched to combine the effectiveness of biologics with the ease of oral administration.
View Article and Find Full Text PDF
Article Synopsis
  • - Generalized Pustular Psoriasis (GPP) is a severe and rare form of psoriasis that affects patients' quality of life, with past treatments mainly mirroring those for plaque psoriasis and often coming with significant side effects.
  • - The underlying mechanisms of GPP involve a complex interplay of the immune system, particularly highlighting the role of the interleukin (IL)-36 pathway, which has been less understood than in other psoriasis types.
  • - New treatments, like spesolimab and imsidolimab, specifically target the IL-36 pathway and have shown promising safety and efficacy results in early clinical trials, suggesting they could become mainstay treatments for GPP.
View Article and Find Full Text PDF

Background: Patients with major depression often suffer from excessive interpersonal sensitivity, although it is not typically measured in antidepressant clinical trials. Preliminary evidence suggests selective serotonin reuptake inhibitors have the capacity to reduce interpersonal sensitivity.

Methods: This was a pooled analysis of data from 1709 patients in three randomized, double-blind, placebo-controlled trials of fluoxetine and paroxetine for acute major depressive disorder.

View Article and Find Full Text PDF

Metastatic melanoma is a deadly disease that claims thousands of lives each year despite the introduction of several immunotherapeutic agents into the clinic over the past decade, inspiring the development of novel therapeutics and the exploration of combination therapies. Our investigations target melanin pigment with melanin-specific radiolabeled antibodies as a strategy to treat metastatic melanoma. In this study, a theranostic approach was applied by first labeling a chimeric antibody targeting melanin, c8C3, with the SPECT radionuclide Pb for microSPECT/CT imaging of C57Bl6 mice bearing B16-F10 melanoma tumors.

View Article and Find Full Text PDF

This study was carried out in order to determine the morphological characteristics, body coat colour distribution, and body dimensions of donkeys raised in Turkey, as well as to determine the relationships between these factors. For this reason, the predictive performance of various machine learning algorithms (i.e.

View Article and Find Full Text PDF

Background: The effect of chronic noise on the middle ear is not fully known. This study aimed to evaluate the middle ear functions of metal workers exposed to chronic noise using wideband tympanometry.

Methods: In this study, 62 male workers exposed to chronic noise and 30 healthy men were included.

View Article and Find Full Text PDF

Signaling circuits crucial to systemic physiology are widespread, yet uncovering their molecular underpinnings remains a barrier to understanding the etiology of many metabolic disorders. Here, we identified a copper-linked signaling circuit activated by disruption of mitochondrial function in the murine liver or heart that resulted in atrophy of the spleen and thymus and caused a peripheral white blood cell deficiency. We demonstrated that the leukopenia was caused by α-fetoprotein, which required copper and the cell surface receptor CCR5 to promote white blood cell death.

View Article and Find Full Text PDF

Objective: To investigate the prognostic value of the magnetic resonance imaging in Bell's palsy patients.

Methods: Patients who were diagnosed and treated with Bell's palsy between October 2013 and March 2016 retrospectively selected. House-Brackmann grades, pre- and post-treatment pure tone audiograms, stapedial reflexes were analyzed and magnetic resonance imaging (MRI) scans with gadolinium-based contrast agents were evaluated.

View Article and Find Full Text PDF

Childhood absence epilepsy (CAE) is a non-convulsive seizure disorder primarily in children characterized by absence seizures. Absence seizures consist of 2.5-5 Hz spike-and-wave discharges (SWDs) detectable using electroencephalography (EEG).

View Article and Find Full Text PDF

Background And Purpose: We sought to understand why (-)-cannabidiol (CBD) and (-)-cannabidiol-dimethylheptyl (CBD-DMH) exhibit distinct pharmacology, despite near identical structures.

Experimental Approach: HEK293A cells expressing either human type 1 cannabinoid (CB ) receptors or CB receptors were treated with CBD or CBD-DMH with or without the CB and CB receptor agonist CP55,940, CB receptor allosteric modulator Org27569 or CB receptor inverse agonist SR144528. Ligand binding, cAMP levels and βarrestin1 recruitment were measured.

View Article and Find Full Text PDF

Cystic fibrosis is caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) channel, which can result in chronic lung disease. The sequence of events leading to lung disease is not fully understood but recent data show that the critical pathogenic event is the loss of the ability to clear bacteria due to abnormal airway surface liquid secretion (ASL). However, whether the inhalation of bacteria triggers ASL secretion and whether this is abnormal in cystic fibrosis has never been tested.

View Article and Find Full Text PDF

Introduction: We aimed to assess central and peripheral nervous system involvement in systemic lupus erythematosus (SLE) patients without any neurological signs and symptoms by performing electrophysiological investigations.

Methods: Thirty-eight SLE patients and 35 healthy volunteers participated in this study. Peripheral nerve conduction and brainstem reflexes were evaluated by performing nerve conduction studies (NCSs) and blink reflex (BR) and masseter inhibitory reflex (MIR) recordings.

View Article and Find Full Text PDF

Background And Purpose: We compared the motor-unit number estimation (MUNE) findings in patients who presented with signs and/or findings associated with carpal tunnel syndrome (CTS) and healthy controls, with the aim of determining if motor-unit loss occurs during the clinically silent period and if there is a correlation between clinical and MUNE findings in CTS patients.

Methods: The study investigated 60 hands of 35 patients with clinical CTS and 60 hands of 34 healthy controls. Routine median and ulnar nerve conduction studies and MUNE analysis according to the multipoint stimulation method were performed.

View Article and Find Full Text PDF

Cystic fibrosis (CF) is an autosomal recessive genetic disorder caused by mutations in the gene encoding for the anion channel cystic fibrosis transmembrane conductance regulator (CFTR). Several organs are affected in CF, but most of the morbidity and mortality comes from lung disease. Recent data show that the initial consequence of CFTR mutation is the failure to eradicate bacteria before the development of inflammation and airway remodeling.

View Article and Find Full Text PDF

Introduction: In this study we investigated the clinical utility of single fiber conduction velocity (SF-CV) testing in the evaluation of motor nerve function in diabetic patients with signs and symptoms of symmetrical distal sensory polyneuropathy (DSP). SF-CV findings were compared with conventional nerve conduction studies (NCS).

Methods: Twenty-eight consecutive type 2 diabetic patients with clinically diagnosed DSP were studied.

View Article and Find Full Text PDF